| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 01/23/2003 | WO2002013798A3 Treatment of the insulin resistance syndrome with selective cgmp pde5 inhibitors |
| 01/23/2003 | WO2002012272A3 Therapeutic anti-melanoma compounds |
| 01/23/2003 | WO2002010405A3 A human disintegrin protein |
| 01/23/2003 | WO2002010363A3 Protein phosphatases |
| 01/23/2003 | WO2002008293A3 Multivalent target binding protein |
| 01/23/2003 | WO2002008262A3 Bstp-5 proteins and related reagents and methods of use thereof |
| 01/23/2003 | WO2002002771A3 Human sparc-homologous (hsparc-h1) gene and methods and uses thereof |
| 01/23/2003 | WO2002002607A3 Acid-modified arabinogalactan protein composition |
| 01/23/2003 | WO2002000258A8 Medicinal compositions for angiogenic therapy |
| 01/23/2003 | WO2001097856A3 An orphan nuclear receptor |
| 01/23/2003 | WO2001093851A3 Compositions and methods for treating neoplastic disease using inhibitors of laminin5beta3 |
| 01/23/2003 | WO2001090358A3 Mammalian receptor proteins; related reagents and methods |
| 01/23/2003 | WO2001090333A3 Recombinant bacterial phytases and uses thereof |
| 01/23/2003 | WO2001089583A3 Glutamic acid decarboxylase (gad)_delivery system for treating neurodegenerative diseases |
| 01/23/2003 | WO2001089548A3 Pharmaceutical use of fibulin-1 |
| 01/23/2003 | WO2001088124A3 Method and reagent for the inhibition of erg |
| 01/23/2003 | WO2001073031A3 Compositions and methods for the therapy and diagnosis of ovarian cancer |
| 01/23/2003 | WO2001063280A3 Inter-alpha-trypsin as a marker for sepsis |
| 01/23/2003 | WO2001063279A3 Method of identifying toxic agents using differential gene expression |
| 01/23/2003 | US20030018987 Animal model for use in the diagnosis and treatment of eating, apoptosis and infectious disorders |
| 01/23/2003 | US20030018984 IGF-I expression system and methods of use |
| 01/23/2003 | US20030018438 Binding compounds and methods for identifying binding compounds |
| 01/23/2003 | US20030018194 New Vitamin D derivatives with cyclopropyl rings in the side chains, process and intermediate products for their production and their use for the production of pharmaceutical agents |
| 01/23/2003 | US20030018193 Beta-alanine derivatives and their use as receptor anatgonists |
| 01/23/2003 | US20030018184 Recombinant C140 receptor, its agonists and antagonists, and nucleic acids encoding the receptor |
| 01/23/2003 | US20030018182 A cDNA encoding a non-endogenous, constitutively activated version of a human G protein-coupled receptor |
| 01/23/2003 | US20030018181 Antiinflammatory agents; culturing; isolation of fusion protein |
| 01/23/2003 | US20030018180 Secreted protein HFEAF41 |
| 01/23/2003 | US20030018168 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 01/23/2003 | US20030018165 Uses of suppressive macrophage activation factors |
| 01/23/2003 | US20030018061 Novel remedies with the use of beta 3 agonist |
| 01/23/2003 | US20030018007 Compositions and methods for inducing gene expression |
| 01/23/2003 | US20030018005 Autoimmune disease; antiinflammatory agents; antiallergens; rheumatic diseases; antitumor agents |
| 01/23/2003 | US20030018003 Rhob as a suppressor of cancer cell growth and cell transformation |
| 01/23/2003 | US20030018001 Antitumor agents; anticarcinogenic agents |
| 01/23/2003 | US20030017996 Antilipemic agents, anticholesterol agents, cardiovascular disorders |
| 01/23/2003 | US20030017995 Dialysis solutions and methods |
| 01/23/2003 | US20030017993 Carbamyloxy compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 01/23/2003 | US20030017992 Crystalline forms |
| 01/23/2003 | US20030017990 Antiinflammatory agents, rheumatic diseases, antiarthritic agents, inflammatory bowel disorders |
| 01/23/2003 | US20030017989 Use of angiotensin I derivative as an agent for the treatment and prevention of infarction-related cardiac injuries and disorders |
| 01/23/2003 | US20030017988 Compositions for treating abnormalities in glomerular filtration, patent ductus arteriosus and osteoporosis |
| 01/23/2003 | US20030017987 Using histones |
| 01/23/2003 | US20030017986 Topical administering bactericide and permeable adjustment protein |
| 01/23/2003 | US20030017985 Molecules that influence pathogen resistance |
| 01/23/2003 | US20030017983 Controlling apoptosis; antiinflammatory agents |
| 01/23/2003 | US20030017982 Genetic engineering; hybrid nucleic acids |
| 01/23/2003 | US20030017981 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 01/23/2003 | US20030017979 Antibody and chemokine constructs and their use in the treatment of infections and immunological diseases |
| 01/23/2003 | US20030017978 Transgenic plant |
| 01/23/2003 | US20030017977 Methods of treating inflammatory skin diseases |
| 01/23/2003 | US20030017976 Anticancer agents; side effect reduction |
| 01/23/2003 | US20030017975 Immunosuppressants; activation of lipopeptide fungicides |
| 01/23/2003 | US20030017973 Fraction extracted from archaebacteria for cosmetic purposes |
| 01/23/2003 | US20030017972 Drug delivery |
| 01/23/2003 | US20030017971 Method for increasing levels of export of mRNA from the nucleus to the cytoplasm by providing in the nucleus recombinant mammalian export protein ALY |
| 01/23/2003 | US20030017970 Wound healing compositions |
| 01/23/2003 | US20030017969 Methods and pharmaceutical compositions for healing wounds |
| 01/23/2003 | US20030017968 Antitumor agents |
| 01/23/2003 | US20030017967 Insecticides; microbiocides; for plants, seeds |
| 01/23/2003 | US20030017964 Administration of agents via the PEPT-2 transporter |
| 01/23/2003 | US20030017617 Mammalian receptor proteins; related reagents and methods |
| 01/23/2003 | US20030017596 Use of parvovirus capsid particles in the inhibition of cell proliferation and migration |
| 01/23/2003 | US20030017586 Nucleotide sequences coding polypeptide for use in the treatment of viral diseases |
| 01/23/2003 | US20030017585 Polypeptide for use in the treatment of cancer, nervous system and autoimmune disorders |
| 01/23/2003 | US20030017584 Anti-TNF antibodies and peptides of human tumor necrosis factor |
| 01/23/2003 | US20030017573 Nucleotide sequences coding polypeptide for use in the treatment of cancer |
| 01/23/2003 | US20030017572 Nucleotide sequences coding polypeptides for use in the treatment of cancer, arthritis alzheimer's and inflammatory diseases |
| 01/23/2003 | US20030017570 Chitinase materials and methods |
| 01/23/2003 | US20030017564 Tryptophanyl-tRNA synthetase derived polypeptides useful for the regulation of angiogenesis |
| 01/23/2003 | US20030017563 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 01/23/2003 | US20030017562 Nucleotide sequences coding polypetide for use in the treatment, prevention and diagnosis of gastrointestinal and apoptosis disorders |
| 01/23/2003 | US20030017550 Nucleotide sequences coding polypeptide for use in the treatment of viral, neoplastic, multiple sclerosis and immunological disorders |
| 01/23/2003 | US20030017548 Proteins for use in treatment of gastrointestinal disorders |
| 01/23/2003 | US20030017546 Analogues of Kunitz protease inhibitor domain of amyloid precursor protein bind to and inhibit activity of serine proteases including kallikrein, plasmin, and coagulation factors VIIa, IXa, Xa, XIa, and XIIa; for treating blood loss |
| 01/23/2003 | US20030017545 Nucleotide sequences coding polypeptides for use in the treatment and prevention of cell proliferation disorders |
| 01/23/2003 | US20030017539 Novel nucleic acid sequences encoding G-protein coupled receptors |
| 01/23/2003 | US20030017537 Amplified genetic expression of genetically engineered hemoglobin; obtain cell, transform with vector coding genetically engineered hemoglobin, express vector, recover hemoglobin |
| 01/23/2003 | US20030017535 Nucleotide sequences coding polypeptide for use in the prevention and treatment of atherosclerosis, cardiovascular and cancerous disorders |
| 01/23/2003 | US20030017530 Nucleotide sequences coding polypeptide for use in the treatment of cancer |
| 01/23/2003 | US20030017529 Peptide for use in human therapeutics and diagnostics |
| 01/23/2003 | US20030017527 Human vanilloid receptor-like proteins |
| 01/23/2003 | US20030017512 Angiostatin receptor |
| 01/23/2003 | US20030017509 Methods for the diagnosis and treatment of insulin-dependent diabetes mellitus |
| 01/23/2003 | US20030017501 Diagnostics and therapeutics for macular degeneration-related disorders |
| 01/23/2003 | US20030017500 Secreted protein HT5GJ57 |
| 01/23/2003 | US20030017498 Nucleotide sequences coding polypeptides for use as tools in pharmacology, diagnostics, biosensors and bioreactors |
| 01/23/2003 | US20030017488 Method for testing a therapeutic or preventive agent for hyperlipidemia |
| 01/23/2003 | US20030017480 Novel genes encoding protein kinase/protein phosphatase |
| 01/23/2003 | US20030017478 Collection of prokaryotic DNA for two hybrid systems Helicobacter pylori protein-protein interactions and application thereof |
| 01/23/2003 | US20030017476 Nucleotide sequence coding polypeptide for use in the treatment and diagnosis of nervous system disorders |
| 01/23/2003 | US20030017466 Diagnosi and treatment of cancer; obtain tissue sample, monitor gene expression in sample, monitor methylation in sample, compare to control, evaluate for cancer |
| 01/23/2003 | US20030017463 Nucleotide sequence coding polypeptide for use in the treatment of heart, cancer and skin disorders |
| 01/23/2003 | US20030017457 Nucleotide sequences coding polypeptide for use in the treatment of nervous system disorders |
| 01/23/2003 | US20030017222 Bitterness-reduced oral pharmaceutical composition |
| 01/23/2003 | US20030017218 Soft tissue anticancer agents |
| 01/23/2003 | US20030017215 Soft tissue anticancer agents |
| 01/23/2003 | US20030017211 Method for drug delivery to the pulmonary system |
| 01/23/2003 | US20030017203 Lamination with a first layer of a pH-lowering agent and a second layer of a peptide, an absorption enhancer to promote bioavailability and enteric coating |
| 01/23/2003 | US20030017174 Containing herpes simplex virus VP22 polypeptides capable of eliciting a cellular immune response |